• CURATIVE DOG
• HYPOALLERGENIC LR
  • INDICATION
  • EFFICACY
  • FOOD SCHEDULE
  • INGREDIENTS
  • ANALYSIS
• HYPOALLERGENIC DR
  • INDICATION
  • EFFICACY
  • FOOD SCHEDULE
  • INGREDIENTS
  • ANALYSIS
• WEIGHT REDUCTION
  • INDICATION
  • EFFICACY
  • FOOD SCHEDULE
  • INGREDIENTS
  • ANALYSIS
• WEIGHT CONTROL
  • INDICATION
  • EFFICACY
  • FOOD SCHEDULE
  • INGREDIENTS
  • ANALYSIS
• ANTI-OSTEOARTHRITIS
  • INDICATION
  • EFFICACY
  • FOOD SCHEDULE
  • INGREDIENTS
  • ANALYSIS
• NEOPLASIA/CARDIAC
  • INDICATION
  • EFFICACY
  • FOOD SCHEDULE
  • INGREDIENTS
  • ANALYSIS
• ATOPY/SENSITIVE
  • INDICATION
  • EFFICACY
  • FOOD SCHEDULE
  • INGREDIENTS
  • ANALYSIS
• RENAL
  • INDICATION
  • EFFICACY
  • FOOD SCHEDULE
  • INGREDIENTS
  • ANALYSIS
• ANTI-STRUVITE
  • INDICATION
  • EFFICACY
  • FOOD SCHEDULE
  • INGREDIENTS
  • ANALYSIS
• PREVENTIVE DOG
• PUPPY
  • INDICATION
  • EFFICACY
  • FOOD SCHEDULE
  • INGREDIENTS
  • ANALYSIS
• JUNIOR
  • INDICATION
  • EFFICACY
  • FOOD SCHEDULE
  • INGREDIENTS
  • ANALYSIS
• ADULT
  • INDICATION
  • EFFICACY
  • FOOD SCHEDULE
  • INGREDIENTS
  • ANALYSIS
• SENIOR
  • INDICATION
  • EFFICACY
  • FOOD SCHEDULE
  • INGREDIENTS
  • ANALYSIS
• CAT

Puppy

Age range

Small breeds: from 4 through 21 weeks.
Medium-sized breeds: from 4 through 26 weeks.
Large breeds: from 4 through 29 weeks.

Goal

- Support of optimum growth in the puppy phase.

- Promotion of the condition of the skin and coat.

- Contribution to good consistency of the faeces.

- Reduction in the risk of metabolic bone diseases.

Characteristics

Characteristic	Ingredient / level	Effect
Optimum content of protein and other nutrients.	Protein 24.9% (15.2 g/MJ); linoleic acid 1.80% (1.10 g/MJ).	Support of growth, condition of skin and coat.
High digestibility of proteins, fats and carbohydrates.	High quality protein, fat and carbohydrate sources.	Good consistency of faeces.
Very low calcium content.	Calcium 0.74% (0.45 g/MJ).	Prevention of metabolic bone diseases, in particular, longitudinal growth suppression and osteochon-drosis.
Very high level of polyunsaturated omega-3 fatty acids.	Eicosapentaenoic acid (EPA) 0.14% (0.09 g/MJ); Docosahexaenoic acid (DHA) 0.14% (0.09 g/MJ).	Promotion of immunity and cognitive ability.